Source Paper
Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V <sub>1b</sub> receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders
Guy Griebel, Jacques Simiand, Claudine Serradeil-Le Gal, Jean Wagnon, Marc Pascal et al.
Proceedings of the National Academy of Sciences • 2002
Forced Swimming Test
Objective: Measure antidepressant-like effects through behavioral despair in forced swimming, assessing the impact of SSR149415 (vasopressin V1b receptor antagonist) on depression-related behaviors in rodents
Gather these items before starting the experiment. Check off items as you prepare.
Equipment1
Not specified • Not specified • Not specified • Not mentioned
Materials2
Sanofi-Synthelabo Recherche • Not applicable • Not specified • Not mentioned
Not specified • Not applicable • Not specified • Not mentioned
Software1
Not specified • Not mentioned
1 item available from ConductScience
As an Amazon Associate, we earn from qualifying purchases. Product links help support this free resource.
Protocol Steps
Drug administration
Administer SSR149415 to test subjects at specified doses
Note: Doses ranged from 10-30 mg/kg administered orally (p.o.)
View evidence from paper
“SSR149415 (10–30 mg/kg, p.o.) produced antidepressant-like effects in both normal and hypophysectomized rats”
Forced swimming test
Place rats in forced swimming apparatus to measure behavioral despair and antidepressant-like effects
Note: Test conducted in both normal and hypophysectomized rats
View evidence from paper
“In the forced swimming test, SSR149415 (10–30 mg/kg, p.o.) produced antidepressant-like effects in both normal and hypophysectomized rats”